Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study

Keystone, E C ; Genovese, M C ; Klareskog, L ; Hsia, E C ; Hall, S T ; Miranda, P C ; Pazdur, J ; Bae, S-C ; Palmer, W ; Zrubek, J ; Wiekowski, M ; Visvanathan, S ; Wu, Z ; Rahman, M U

Annals of the rheumatic diseases, 2009-06, Vol.68 (6), p.789-796 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível